U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

IMPACT trial is evaluating the safety and efficacy of pemvidutide in approximately 190 subjects with MASH; top-line efficacy data expected in Q2 ...

Obesity, diabetes, and Polycystic Ovarian Syndrome (PCOS) are the key reasons why India is seeing a rise in gynecological ...

Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, ...

Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...

The maker of a weight loss drug has asked regulators to allow them to expand the use of the medication down to the age of six. It comes as Liraglutide, a drug approved to treat obesity in adults and ...

Roche’s current pharmaceutical portfolio will deliver growth through at least 2027, the company said. Schinecker has already ...

Non-Alcoholic Fatty Liver Disease (NAFLD), closely linked to obesity, diabetes, and cardiovascular diseases, is a growing ...

In a recent study published in the New England Journal of Medicine, researchers found that Novo Nordisk's drug liraglutide, sold under the brand names Saxenda and Victoza, led to a reduction in body ...

New research published in The Journal of Nutrition suggests that adding selenium-rich Brazil nuts to your diet could help ...

Amgen's strong dividend growth, with a 2.8% yield and consistent hikes since 2011. Read what makes AMGN stock is a worthy ...